Broadly neutralizing antibodies (bNAbs) that are able to cross-neutralize diverse HIV-1 strains by targeting structurally or functionally conserved regions of Env develop in some individuals later in infection (9, –, 14). The gene discussed is ERVW-1; the disease is infection.